DARBAZINE SPANSULE CAPS NO. 1 CAPSULE (SUSTAINED-RELEASE)
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PROCHLORPERAZINE MALEATE; ISOPROPAMIDE IODIDE
Available from:
NORDEN LABORATORIES INC.
Dosage:
5.4MG; 1.67MG
Pharmaceutical form:
CAPSULE (SUSTAINED-RELEASE)
Composition:
PROCHLORPERAZINE MALEATE 5.4MG; ISOPROPAMIDE IODIDE 1.67MG
Administration route:
ORAL
Units in package:
250/500/1000
Prescription type:
Prescription
Therapeutic group:
DOG OR CAT
Product summary:
Active ingredient group (AIG) number: 0206183002
Authorization status:
CANCELLED POST MARKET
Authorization date:
1996-09-10
